Article Details

M&As slow as biopharma dealmaking value jumps 32% in September 2025 | BioWorld

Retrieved on: 2025-10-10 22:23:51

Tags for this article:

Click the tags to see associated articles and topics

M&As slow as biopharma dealmaking value jumps 32% in September 2025 | BioWorld. View article details on hiswai:

Excerpt

Biopharma dealmaking was up 32% month over month in September, reaching $27.15 billion in total value, up from $20.52 billion in August.

Article found on: www.bioworld.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo